Scarica l'app Stockscreener
15.58
2.99%
0.41
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ADPT Giù?
Forum
Previsione
Precedente Chiudi:
$15.17
Aprire:
$15.5
Volume 24 ore:
231.96K
Relative Volume:
0.12
Capitalizzazione di mercato:
$2.37B
Reddito:
$177.28M
Utile/perdita netta:
$-195.24M
Rapporto P/E:
-11.63
EPS:
-1.34
Flusso di cassa netto:
$-114.54M
1 W Prestazione:
+7.97%
1M Prestazione:
+23.89%
6M Prestazione:
+96.76%
1 anno Prestazione:
+216.26%
Intervallo 1D:
$15.21
$15.94
Intervallo di 1 settimana:
$14.11
$15.94
Portata 52W:
$4.27
$15.94
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
Nome
Adaptive Biotechnologies Corp
Settore
Industria
Telefono
206-659-0067
Indirizzo
1165 EASTLAKE AVE E, SEATTLE, WA
Confronta ADPT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
15.56 | 2.31B | 177.28M | -195.24M | -114.54M | -1.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
406.28 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.63 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.19 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
800.57 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
328.93 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-30 | Iniziato | Guggenheim | Buy |
| 2025-06-18 | Iniziato | Craig Hallum | Buy |
| 2025-03-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-12-21 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | Iniziato | Credit Suisse | Underperform |
| 2022-06-03 | Iniziato | Piper Sandler | Neutral |
| 2022-02-16 | Reiterato | BTIG Research | Buy |
| 2022-02-16 | Reiterato | BofA Securities | Buy |
| 2022-02-16 | Reiterato | Goldman | Neutral |
| 2022-02-16 | Reiterato | JP Morgan | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-03-03 | Downgrade | Goldman | Buy → Neutral |
| 2020-10-08 | Ripresa | BTIG Research | Buy |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-06-03 | Iniziato | Goldman | Buy |
| 2019-07-23 | Iniziato | BTIG Research | Buy |
| 2019-07-22 | Iniziato | BofA/Merrill | Buy |
| 2019-07-22 | Iniziato | Cowen | Outperform |
| 2019-07-22 | Iniziato | Goldman | Neutral |
| 2019-07-22 | Iniziato | Guggenheim | Buy |
| 2019-07-22 | Iniziato | William Blair | Outperform |
Mostra tutto
Adaptive Biotechnologies Corp Borsa (ADPT) Ultime notizie
Adaptive Biotechnologies Corp. Hits New 52-Week High of $15.57 - Markets Mojo
Is Adaptive Biotechnologies Corporation stock near bottom after declineEarnings Recap Report & Free High Return Stock Watch Alerts - newser.com
Adaptive Biotechnologies Hits Day High with 8.36% Surge in Stock Price - Markets Mojo
Risk vs reward if holding onto Adaptive Biotechnologies CorporationLong Setup & Risk Controlled Daily Trade Plans - newser.com
Will Adaptive Biotechnologies Corporation bounce back from current support2025 Short Interest & Target Return Focused Stock Picks - newser.com
Adaptive Biotechnologies stock hits 52-week high at $15.29 By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies stock hits 52-week high at $15.29 - Investing.com
Adaptive Biotechnologies (ADPT): A Fresh Analyst Spotlight Prompts a Closer Look at Valuation and Growth Potential - simplywall.st
What technical signals suggest for Adaptive Biotechnologies Corporation stockJuly 2025 Analyst Calls & Intraday High Probability Setup Alerts - newser.com
Can volume confirm reversal in Adaptive Biotechnologies CorporationJuly 2025 Selloffs & Weekly Momentum Picks - newser.com
Why analysts upgrade Adaptive Biotechnologies Corporation stock2025 Biggest Moves & Low Risk High Win Rate Picks - newser.com
Is Adaptive Biotechnologies Corporation (1HM) stock bottoming after sell offJuly 2025 Closing Moves & Free Low Drawdown Momentum Trade Ideas - newser.com
Is Adaptive Biotechnologies Corporation trending in predictive chart modelsQuarterly Risk Review & Free Weekly Watchlist of Top Performers - newser.com
What recovery options are there for Adaptive Biotechnologies CorporationJuly 2025 Selloffs & Breakout Confirmation Trade Signals - newser.com
Why Adaptive Biotechnologies (ADPT) Is Up 8.5% After clonoSEQ’s Integration With Flatiron Health’s OncoEMR - simplywall.st
Is Adaptive Biotechnologies Corporation stock poised for growthJuly 2025 Earnings & Reliable Trade Execution Plans - newser.com
Adaptive Biotechnologies Corporation stock momentum explainedJuly 2025 WrapUp & Free Daily Entry Point Trade Alerts - newser.com
Adaptive Biotechnologies Corp. Hits New 52-Week High of $15.26 - Markets Mojo
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Adaptive Biotechnologies Corp. Hits New 52-Week High at $15.04 - Markets Mojo
Adaptive Biotechnologies Hits Day High with 13.94% Surge in Stock Price - Markets Mojo
Adaptive Biotechnologies stock hits 52-week high at $14.49 By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies (NASDAQ:ADPT) Now Covered by Analysts at Guggenheim - Defense World
A Glimpse Into The Expert Outlook On Adaptive Biotechnologies Through 4 Analysts - Benzinga
Guggenheim Initiates Coverage on ADPT with 'Buy' Rating | ADPT S - GuruFocus
Adaptive Biotechnologies stock hits 52-week high at $14.49 - Investing.com
Guggenheim Initiates Adaptive Biotechnologies(ADPT.US) With Buy Rating, Announces Target Price $20 - 富途牛牛
Will Adaptive Biotechnologies Corporation (1HM) stock gain from lower interest ratesWeekly Investment Summary & Free Real-Time Volume Trigger Notifications - newser.com
Real time alert setup for Adaptive Biotechnologies Corporation performanceWeekly Risk Summary & Step-by-Step Trade Execution Guides - newser.com
Is Adaptive Biotechnologies Corporation (1HM) stock dividend growth reliableCEO Change & Entry Point Strategy Guides - newser.com
Adaptive Biotechnologies Corporation stock outlook for YEARSwing Trade & Safe Swing Trade Setups - newser.com
The Bull Case For Adaptive Biotechnologies (ADPT) Could Change Following Analyst Upgraded Earnings Outlook - Yahoo Finance
Adaptive Biotechnologies (ADPT): Exploring Valuation After Recent Share Price Momentum - Yahoo Finance
Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year? - Yahoo Finance
Adaptive Biotechnologies Stock Hits Day Low of $12.72 Amid Price Pressure - Markets Mojo
Adaptive Biotechnologies Corp. Hits New 52-Week High at $14.27 - Markets Mojo
Adaptive Biotechnologies Corp. Hits New 52-Week High of $14.47 - Markets Mojo
Adaptive Biotechnologies Corp Azioni (ADPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Adaptive Biotechnologies Corp Azioni (ADPT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S | Chief Scientific Officer |
May 01 '25 |
Option Exercise |
6.32 |
68,412 |
432,364 |
1,347,936 |
| ROBINS HARLAN S | Chief Scientific Officer |
May 01 '25 |
Sale |
7.35 |
68,412 |
502,828 |
1,279,524 |
0.11%
2.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):